Lower dose cetrorelix for ICSI cycles
Part of Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study compares a half dose of the medication cetrorelix with the usual full dose during ICSI (a type of IVF) to see if the lower dose works as well with fewer side effects. It is for younger women with normal ovarian reserve and a higher BMI.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are younger than 35 years old.
- Your ovarian reserve is normal, meaning your AMH level is 1.2 ng/mL or higher and your antral follicle count is between 5 and 15.
- Your body mass index (BMI) is 25 kg/m² or higher.
- You are willing to give written consent to participate.
- You do not have any condition that makes ovarian stimulation or pregnancy unsafe, and you have no congenital uterine abnormalities or major issues inside the uterus.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares a generic version of cetrorelix acetate (a medication used to control ovulation) to the brand-name version during IVF. It aims to see if the generic works just as well for women undergoing ovarian stimulation.
This trial compares two doses of follicle-stimulating hormone (FSH) to find out which dose helps women with normal ovarian reserve have better IVF outcomes. It aims to improve the chances of a successful pregnancy.
This study tests a one-time injection medicine (corifollitropin alfa) to help older women produce eggs for IVF. It aims to see if this medicine is safe and works well for women aged 36 to 40 with normal ovarian function.
This trial compares two ways of taking a medication that helps control your hormones during IVF (in vitro fertilization), one as a pill and one as an injection, to see if the pill works just as well. It also includes a third group who get a different type of hormone treatment. This could help make IVF more convenient for you.
This trial tests a fixed dose of the hormone follitropin delta (Rekovelle) to stimulate the ovaries before intrauterine insemination (IUI). It aims to see if this approach works well for women with regular cycles who are starting IUI for the first time.
This study tests if a combination of two hormone drugs (follitropin alfa/lutropin alfa) works as well as another drug (hMG) for Japanese women with low LH and FSH levels who are doing in vitro fertilization (IVF). The goal is to help them produce eggs for pregnancy.
Hear when a new Infertility trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.